Cargando…
Integration of mechanistic and pharmacokinetic information to derive oral reference dose and margin‐of‐exposure values for hexavalent chromium
The current US Environmental Protection Agency (EPA) reference dose (RfD) for oral exposure to chromium, 0.003 mg kg(−1) day(−1), is based on a no‐observable‐adverse‐effect‐level from a 1958 bioassay of rats exposed to ≤25 ppm hexavalent chromium [Cr(VI)] in drinking water. EPA characterizes the con...
Autores principales: | Thompson, Chad M., Kirman, Christopher R., Hays, Sean M., Suh, Mina, Harvey, Seneca E., Proctor, Deborah M., Rager, Julia E., Haws, Laurie C., Harris, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813206/ https://www.ncbi.nlm.nih.gov/pubmed/29064106 http://dx.doi.org/10.1002/jat.3545 |
Ejemplares similares
-
A chronic oral reference dose for hexavalent chromium-induced intestinal cancer†
por: Thompson, Chad M, et al.
Publicado: (2014) -
Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans
por: Thompson, Chad M., et al.
Publicado: (2013) -
Comparison of Toxicity and Recovery in the Duodenum of B6C3F1 Mice Following Treatment with Intestinal Carcinogens Captan, Folpet, and Hexavalent Chromium
por: Thompson, Chad M., et al.
Publicado: (2017) -
Application of the U.S. EPA Mode of Action Framework for Purposes of Guiding Future Research: A Case Study Involving the Oral Carcinogenicity of Hexavalent Chromium
por: Thompson, Chad M., et al.
Publicado: (2011) -
Comparison of the Effects of Hexavalent Chromium in the Alimentary Canal of F344 Rats and B6C3F1 Mice Following Exposure in Drinking Water: Implications for Carcinogenic Modes of Action
por: Thompson, Chad M., et al.
Publicado: (2012)